JPWO2021110561A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021110561A5 JPWO2021110561A5 JP2022533108A JP2022533108A JPWO2021110561A5 JP WO2021110561 A5 JPWO2021110561 A5 JP WO2021110561A5 JP 2022533108 A JP2022533108 A JP 2022533108A JP 2022533108 A JP2022533108 A JP 2022533108A JP WO2021110561 A5 JPWO2021110561 A5 JP WO2021110561A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- agonist
- sequence
- interferon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19306551.3 | 2019-12-03 | ||
| EP19306551 | 2019-12-03 | ||
| EP19306572.9 | 2019-12-04 | ||
| EP19306572 | 2019-12-04 | ||
| PCT/EP2020/083737 WO2021110561A1 (en) | 2019-12-03 | 2020-11-27 | Interferon-associated antigen binding proteins for use in treating hepatitis b infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023505169A JP2023505169A (ja) | 2023-02-08 |
| JP2023505169A5 JP2023505169A5 (https=) | 2023-12-05 |
| JPWO2021110561A5 true JPWO2021110561A5 (https=) | 2023-12-05 |
Family
ID=73554457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533108A Pending JP2023505169A (ja) | 2019-12-03 | 2020-11-27 | Ｂ型肝炎感染の治療における使用のためのインターフェロン会合抗原結合タンパク質 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230028476A1 (https=) |
| EP (1) | EP4069290A1 (https=) |
| JP (1) | JP2023505169A (https=) |
| KR (1) | KR20220109435A (https=) |
| CN (1) | CN115052626A (https=) |
| AU (1) | AU2020397416A1 (https=) |
| BR (1) | BR112022010425A2 (https=) |
| CA (1) | CA3163356A1 (https=) |
| IL (1) | IL293449A (https=) |
| WO (1) | WO2021110561A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220109436A (ko) | 2019-12-03 | 2022-08-04 | 에보텍 인터내셔널 게엠베하 | 인터페론-결합된 항원 결합 단백질 및 이의 용도 |
| WO2021231773A1 (en) | 2020-05-13 | 2021-11-18 | Good Therapeutics, Inc. | Compositions of protein complexes and methods of use thereof |
| WO2022258720A1 (en) * | 2021-06-09 | 2022-12-15 | Evotec International Gmbh | Interferon-associated antigen binding proteins for use for the treatment or prevention of coronavirus infection |
| WO2024126289A1 (en) * | 2022-12-13 | 2024-06-20 | Evotec International Gmbh | Interferon-associated antigen binding proteins for use for the treatment or prevention of influenza virus infection |
| WO2024126294A1 (en) * | 2022-12-13 | 2024-06-20 | Evotec International Gmbh | Interferon-associated antigen binding proteins for use for the treatment or prevention of parainfluenza virus infection |
| WO2024126293A1 (en) * | 2022-12-13 | 2024-06-20 | Evotec International Gmbh | Interferon-associated antigen binding proteins for use for the treatment or prevention of respiratory syncytial virus infection |
| WO2024213635A1 (en) * | 2023-04-12 | 2024-10-17 | Evotec International Gmbh | Interferon-associated antigen binding proteins for use for the treatment or prevention of hepatitis delta virus infection |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| DE3675588D1 (de) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist. |
| US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
| WO1987000201A1 (en) | 1985-07-05 | 1987-01-15 | Whitehead Institute For Biomedical Research | Epithelial cells expressing foreign genetic material |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| ATE87659T1 (de) | 1986-09-02 | 1993-04-15 | Enzon Lab Inc | Bindungsmolekuele mit einzelpolypeptidkette. |
| US5750172A (en) | 1987-06-23 | 1998-05-12 | Pharming B.V. | Transgenic non human mammal milk |
| EP0378576B1 (en) | 1987-09-11 | 1995-01-18 | Whitehead Institute For Biomedical Research | Transduced fibroblasts and uses therefor |
| WO1989005345A1 (en) | 1987-12-11 | 1989-06-15 | Whitehead Institute For Biomedical Research | Genetic modification of endothelial cells |
| JP2917998B2 (ja) | 1988-02-05 | 1999-07-12 | ホワイトヘッド・インスティチュート・フォー・バイオメディカル・リサーチ | 修飾された肝細胞およびその用途 |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5328470A (en) | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| JP3249516B2 (ja) | 1990-10-31 | 2002-01-21 | ソマティクス セラピー コーポレイション | 遺伝子治療のためのレトロウイルスのベクター |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| DE69424687T2 (de) | 1993-03-09 | 2000-09-07 | Genzyme Corp., Cambridge | Verfahren zur isolierung von proteinen aus milch |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| GB9524973D0 (en) | 1995-12-06 | 1996-02-07 | Lynxvale Ltd | Viral vectors |
| US6133426A (en) | 1997-02-21 | 2000-10-17 | Genentech, Inc. | Humanized anti-IL-8 monoclonal antibodies |
| US6517529B1 (en) | 1999-11-24 | 2003-02-11 | Radius International Limited Partnership | Hemodialysis catheter |
| WO2007130493A2 (en) * | 2006-05-03 | 2007-11-15 | Regents Of The University Of Colorado | Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity |
| CA2805564A1 (en) * | 2010-08-05 | 2012-02-09 | Stefan Jenewein | Anti-mhc antibody anti-viral cytokine fusion protein |
| ES2985566T3 (es) * | 2016-03-04 | 2024-11-06 | Univ Rockefeller | Anticuerpos contra CD40 con actividad agonista mejorada |
| US11324819B2 (en) * | 2016-04-06 | 2022-05-10 | University Of Washington | Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen |
| WO2018087345A1 (en) * | 2016-11-14 | 2018-05-17 | F. Hoffmann-La Roche Ag | COMBINATION THERAPY OF AN HBsAg INHIBITOR, A NUCLEOS(T)IDE ANALOGUE AND AN INTERFERON |
| SG11202011815SA (en) * | 2018-06-01 | 2020-12-30 | Sanofi Sa | Combination therapy for treating hepatitis b virus infection |
-
2020
- 2020-11-27 BR BR112022010425A patent/BR112022010425A2/pt unknown
- 2020-11-27 WO PCT/EP2020/083737 patent/WO2021110561A1/en not_active Ceased
- 2020-11-27 KR KR1020227022257A patent/KR20220109435A/ko active Pending
- 2020-11-27 EP EP20812046.9A patent/EP4069290A1/en active Pending
- 2020-11-27 AU AU2020397416A patent/AU2020397416A1/en active Pending
- 2020-11-27 CA CA3163356A patent/CA3163356A1/en active Pending
- 2020-11-27 US US17/756,797 patent/US20230028476A1/en not_active Abandoned
- 2020-11-27 IL IL293449A patent/IL293449A/en unknown
- 2020-11-27 JP JP2022533108A patent/JP2023505169A/ja active Pending
- 2020-11-27 CN CN202080095495.4A patent/CN115052626A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022079549A5 (https=) | ||
| JP2018535650A5 (https=) | ||
| JP2018108081A5 (https=) | ||
| JP2021524267A5 (https=) | ||
| FI4045533T3 (fi) | Ihmisen monoklonaalisia vasta-aineita vakavalle akuutille koronavirus 2 -hengityselinoireyhtymälle (sars-cov-2) | |
| JP2012504955A5 (https=) | ||
| JP2018521638A5 (https=) | ||
| JP2023071956A5 (https=) | ||
| JP2010516229A5 (https=) | ||
| JP2017533694A5 (https=) | ||
| JP2010534478A5 (https=) | ||
| JP2011528902A5 (https=) | ||
| JP2011528901A5 (https=) | ||
| RU2009136677A (ru) | Рекомбинантные антитела для лечения респираторно-синцитиальных вирусных инфекций | |
| JP2018537421A5 (https=) | ||
| JP2011505867A5 (https=) | ||
| JP2017537084A5 (https=) | ||
| JP2025032102A5 (https=) | ||
| RU2013106217A (ru) | Гибридный белок из антитела против мнс и противовирусного цитокина | |
| RU2765878C2 (ru) | Антитела для лечения инфекции гепатитом в и связанных с ней заболеваний | |
| JP2018520334A5 (https=) | ||
| JP2018522540A5 (https=) | ||
| JP2024109911A5 (https=) | ||
| CN118184774A (zh) | 中和SARS-CoV-2及变异株的全人源抗体及应用 | |
| JP2018514193A5 (https=) |